Imperial College London
Portrait Picture

DrChloeBloom

Faculty of Medicine, National Heart & Lung Institute

Clinical Senior Lecturer in Respiratory Epidemiology
 
 
 
//

Contact

 

chloe.bloom06

 
 
//

Location

 

Emmanuel Kaye BuildingRoyal Brompton Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Bloom:2021,
author = {Bloom, C and Wong, E and Hickman, K and Elkin, S},
journal = {npj Primary Care Respiratory Medicine},
title = {Influence of the first wave of COVID-19 on asthma inhaler prescriptions},
url = {https://www.nature.com/articles/s41533-021-00260-w},
volume = {31},
year = {2021}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - In the beginning of the COVID-19 pandemic there were major concerns regarding the huge demand for asthma inhalers. Using primary care medical records for 614,700 asthma patients between January and June 2020, we found that there was a substantial increase in inhalers solely in March 2020. Patients significantly associated with receiving higher inhaled corticosteroid prescriptions were younger, of higher socioeconomic status and had milder asthma.
AU  - Bloom,C
AU  - Wong,E
AU  - Hickman,K
AU  - Elkin,S
PY  - 2021///
SN  - 2055-1010
TI  - Influence of the first wave of COVID-19 on asthma inhaler prescriptions
T2  - npj Primary Care Respiratory Medicine
UR  - https://www.nature.com/articles/s41533-021-00260-w
UR  - http://hdl.handle.net/10044/1/92379
VL  - 31
ER  -
Download